Intracellular Bacteria and Protozoa - Intracellular Delivery: Fundamentals and Applications - page 796

Begg EJ, Barclay ML (1995) Aminoglycosides-50 years on. British J Clin Pharmacol 39:
597-603
Ben Salah A, Zakraoui H, Zaatour A, Ftaiti A, Zaafouri B, Garraoui A, Olliaro PL, Dellagi K, Ben
Ismail R (1995) A randomized, placebo-controlled trial in Tunisia treating cutaneous leishma-
niasis with paromomycin ointment. Am J Trop Med Hyg 53: 162-166
Ben Salah A, Buffet PA, Morizot G, Ben Massoud N, Zâatour A, Ben Alaya N, Haj Hamida NB,
El Ahmadi Z, Downs MT, Smith PL, Dellagi K, Grögl M (2009) WR279,396, a third genera-
tion aminoglycoside ointment for the treatment of Leishmania major cutaneous leishmaniasis:
a phase 2, randomized, double blind, placebo controlled study. PLoS Negl Trop Dis 3(5):
e432
Berman JD, Hanson WL, Chapman WL, Alving CR, Lopez-Berestein G (1986) Antileishmanial
activity of liposome-encapsulated amphotericin B in hamsters and monkeys. Antimicrob
Agents Chemother 30: 847-851
Bermudez LE (1994) Use of liposome preparation to treat mycobacterial infections. Immunobiology
191 (4-5): 578-583
Bermudez LE, Yau-Young AO, Lin J-P, Cogger J, Young LS (1990) Treatment of disseminated
Mycobacterium avium complex infection of beige mice with liposome-encapsulated amino-
glycosides. J Infect Dis 161: 1262-1268
Bern C, Adler-Moore J, Berenguer J, Boelaert M, den Boer M, Davidson RN, Figueras C, Gradoni L,
Kafetzis DA, Ritmeijer K, Rosenthal E, Royce C, Russo R, Sundar S, Alvar J (2006)
Liposomal amphotericin B for the treatment of visceral leishmaniasis. Clin Infect Dis 43:
917-924
Bharatwaj B, Wu L, Whittum-Hudson JA, da Rocha SRP (2010) The potential for the noninvasive
delivery of polymeric nanocarriers using propellant-based inhalers in the treatment of
Chlamydial respiratory infections. Biomaterials 31: 7376-7385
Biagini GA, Ward SA, Bray PG (2005) Malaria parasite transporters as a drug-delivery strategy.
Trends Parasitol 21: 299-301
Birmingham CL, Smith AC, Bakowski MA, Yoshimori T, Brumell JH (2006) Autophagy controls
Salmonella infection in response to damage to the Salmonella-containing vacuole. J Biol
Chem 281: 11374-11383
Blais J, Chamberland S (1994) Intracellular accumulation of tilmicosin in primary swine alveolar
macrophages. Proc Int Pig Vet Soc 13: 331
Brown M, Noursadeghi M, Boyle J, Davidson RN (2005) Successful liposomal amphotericin
B treatment of Leishmania braziliensis cutaneous leishmaniasis. Br J Dermatol 153: 203-205
Cançado JR (1999) Criteria of Chagas disease cure. Mem Inst Oswaldo Cruz 94: 331-336
Carneiro G, Santos DC, Oliveira MC, Fernandes AP, Ferreira LS, Ramaldes GA, Nunan EA,
Ferreira LA (2010) Topical delivery and in vivo antileishmanial activity of paromomycin-
loaded liposomes for treatment of cutaneous leishmaniasis. J Liposome Res 20(1):16-23.
Carter PB, Collins FM (1974) The route of enteric infection in normal mice. J Exp Med 139:
1189-1203
Centers for Disease Control and Prevention, CDC. http://www.cdc.gov/ncidod/dbmd/diseaseinfo/
mycobacteriumavium_t.htm
Chadwick S, Kriegel C, Amiji M (2010) Nanotechnology solutions for mucosal immunization.
Adv Drug Del Rev 62: 394-407
Chandra SA, Agrawal K, Gupta CM (1991) Chloroquine delivery to erythrocytes in Plasmodium
berghei -infected mice using antibody bearing liposomes as drug vehicles. J Biosci 16:
37-144
Chimanuka B, Gabriëls M, Detaevernier MR, Plaizier-Vercammen JA (2002) Preparation of beta-
artemether liposomes, their HPLC-UV evaluation and relevance for clearing recrudescent
parasitaemia in Plasmodium chabaudi malaria-infected mice. J Pharm Biomed 28: 13-22
Chimote G, Banerjee R (2008) Effect of mycobacterial lipids on surface properties of Curosurf:
implications for lung surfactant dysfunction in tuberculosis. Respir Physiol Neurobiol 162:
73-9